ME1 and breast carcinoma: Given the critical roles of ME1 expression in breast cancer, we performed Kaplan-Meier analyses to evaluate whether ME1 is a prognostic indicator for clinical outcomes by analyzing NKI295 and GSE25066 datasets22,23.